BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19188798)

  • 21. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
    Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
    Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential conditions causing impairment of selective hepatobiliary enhancement of gadobenate dimeglumine-enhanced delayed magnetic resonance imaging.
    Kim H; Kim MJ; Park MS; Cha SW; Lim JS; Yoo HS; Kim KW
    J Comput Assist Tomogr; 2010 Jan; 34(1):113-20. PubMed ID: 20118733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
    Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
    J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images.
    Marin D; Iannaccone R; Catalano C; Passariello R
    J Magn Reson Imaging; 2006 Sep; 24(3):690-4. PubMed ID: 16878304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative MRI of potential living-donor-related liver transplantation using a single dose of gadobenate dimeglumine.
    Lim JS; Kim MJ; Kim JH; Kim SI; Choi JS; Park MS; Oh YT; Yoo HS; Lee JT; Kim KW
    AJR Am J Roentgenol; 2005 Aug; 185(2):424-31. PubMed ID: 16037515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings.
    Ergen FB; Akata D; Sarikaya B; Kerimoglu U; Hayran M; Akhan O; Hussain HK
    J Comput Assist Tomogr; 2008; 32(1):54-60. PubMed ID: 18303288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
    Chung WS; Kim MJ; Chung YE; Kim YE; Park MS; Choi JY; Kim KW
    J Magn Reson Imaging; 2011 Aug; 34(2):345-53. PubMed ID: 21702068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging.
    Kim YK; Lee JM; Kim CS; Chung GH; Kim CY; Kim IH
    Eur Radiol; 2005 Feb; 15(2):220-8. PubMed ID: 15624108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI.
    Lee MS; Lee JY; Kim SH; Park HS; Kim SH; Lee JM; Han JK; Choi BI
    J Magn Reson Imaging; 2011 Jan; 33(1):149-59. PubMed ID: 21182133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application.
    Caudana R; Morana G; Pirovano GP; Nicoli N; Portuese A; Spinazzi A; Di Rito R; Pistolesi GF
    Radiology; 1996 May; 199(2):513-20. PubMed ID: 8668804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of 3.0-Tesla rectal magnetic resonance imaging in preoperative local staging of primary rectal cancer.
    Kim SH; Lee JM; Lee MW; Kim GH; Han JK; Choi BI
    Invest Radiol; 2008 Aug; 43(8):587-93. PubMed ID: 18648259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation.
    Vogl TJ; Stupavsky A; Pegios W; Hammerstingl R; Mack M; Diebold T; Lodemann KP; Neuhaus P; Felix R
    Radiology; 1997 Dec; 205(3):721-8. PubMed ID: 9393527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the longitudinal tumor extent of bile duct cancer: value of adding gadolinium-enhanced dynamic imaging to unenhanced images and magnetic resonance cholangiography.
    Kim HJ; Lee JM; Kim SH; Han JK; Lee JY; Choi JY; Kim KH; Kim JY; Lee MW; Kim SJ; Choi BI
    J Comput Assist Tomogr; 2007; 31(3):469-74. PubMed ID: 17538298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI.
    Kim YK; Lee YH; Kim CS; Lee MW
    Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions.
    Kim YK; Lee JM; Kim CS
    Eur Radiol; 2004 Jan; 14(1):5-13. PubMed ID: 14600778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI.
    Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A
    J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.
    Grazioli L; Morana G; Federle MP; Brancatelli G; Testoni M; Kirchin MA; Menni K; Olivetti L; Nicoli N; Procacci C
    Radiology; 2001 Dec; 221(3):731-9. PubMed ID: 11719669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.